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Abstract 
 
Objective(s) 
Although, type 2 diabetes is the most frequent type of diabetes, its main cause is yet to be clarified. Several 
environmental and genetic parameters are believed to be involved in diabetes. It has also been established 
that cytokines play key roles in pathogenesis of diabetes. Expression of cytokines is different from person to 
person and in different societies. Several studies showed that polymorphisms of +874 of interferon-gamma 
(IFN-γ) and -590 of interleukin-4 (IL-4) are associated with the regulation of expression of these genes. This 
study was aimed to find polymorphisms of these regions in type 2 diabetes patients. 
Materials and Methods 
In this experimental study peripheral blood samples were collected from 160 type 2 diabetic patients and 160 
healthy controls. DNA was extracted by salting out method. Polymorphisms of +874 of IFN-γ and -590 of 
IL-4 were analyzed by ARMS-PCR and RFLP-PCR. 
Results 
Our findings indicated that TT genotype of IFN-γ was increased in type 2 diabetic patients compared to the 
control but difference was not significant. Our results didn’t show any significant difference between IL-4 
genotype in diabetic and healthy controls either. 
Conclusion 
Our results suggested that TT genotype of IFN-γ can be associated with diabetes. This association can be 
described by the fact that over expression of IFN-γ  shifts immune system to Th1; therefore, pancreatic cells 
can be miscarried by immune cells.  
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Introduction 
The main cause of type 2 diabetes is unclear but 
it is well defined that the disease imposes several 
problems to the patients (1). Several research 
groups reported that cytokine imbalance is 
involved in pathogenesis of       type 2 diabetes 
(2). Investigators of this field believe that type 2 
diabetes is associated with immune system and 
in turn is related to the alteration of Th2 to Th1 
immune response patterns (3). Gene 
polymorphisms play key roles in regulation of 
cytokines expression (4), for example 
substitution of C by T in -590 position of IL-4 
gene causes reduced cytokine expression while 
TT form up-regulates production of this cytokine 
(4). IL-4 is a Th2 cytokine which suppresses 
cellular immunity, thus, prevents immune-
mediated destruction of langerhanse cells (5). In 
contrast, IFN-γ is a Th1 cytokine which supports 
immune system to perform cytolysis of target 
cells (6). Previous studies showed that 
subsituation of T with A in +874 of IFN-γ gene 
leads to a decreased expression of this cytokine, 
so that TT causes maximum expression, AT 
mediate expression and AA minimum IFN-γ 
expression (4). Therefore, based on above 
introductory comments this project was aimed to 
analyze polymorphisms of -590 region in IL-4 as 
a Th2 and +874 region in IFN-γ as a Th1 
response cytokine in type 2 diabetic patients.     
 
Material and Methods 
Subjects 
In this experimental case-control study 
peripheral blood were collected from 160 type 
2 diabetic patients and 160 healthy controls. 
Blood sugar was measured before PCR 
analysis. Fasting blood sugar was measured 
three times during 9 month in all patients and 
controls. Patients were selected randomly 
among diabetic patients of Ali Ebne Abitaleb 
Diabetes Clinic and control cases were 
selected from population with same age, sex, 
ethnic group and socio-economic status after 
approval by Rafsanjan University of Medical 
Science ethical committee. All the patients and 
control cases were from Rafsanjan, Iran.     
 
Genotyping 
DNA was extracted from anti-coagulant 
treated whole blood using salting out method 
(6). IL-4 (-590C/T) gene polymorphism was 
analyzed by polymerase chain reaction-
restricted fragment length polymorphism 
(PCR-RFLP) method. The sequences of 
primers were as follow:  
F: 5
′-TAAACTTGGGAGAACATGGT-3
′  
R: 5
′-TGGGGAAAGATAGAGTAATA-3
′ 
PCR was performed in 50 µl of final volume 
in the following conditions: 5 µl of Taq DNA 
polymerase buffer (10x), 1 µl of MgCl2 (stock 
concentration 1.5 mM), 1 µl of each dNTP 
((dATP, dCTP, dGTP, dTTP) stock 
concentration of 10 mM), 2 µl of each primer 
pair (Table 1 (forward and reverse), stock 
concentration of 25 ng/µl), 2 µl of prepared 
DNA and sterile double distilled water to a 
final volume of 50 µl. The PCR thermocycler 
was run with the following program: one cycle 
of 95 °C for 2 min, 95 °C for 1 min 
(denaturation),  1  min  at  53ºC  (annealing),           
72 °C for 40 sec (elongation) followed by 30 
cycles of 94 ºC for 20 sec, 65 ºC for 20 sec and 
72 ºC for 2 min. During the last 45 seconds of 
first stage 0.3 µl of Taq DNA polymerase was 
added to the mixture. The PCR product of IL-4 
(-590C/T) was a 195 bp fragment and was 
digested with AvaII into 175 and 20 bp 
fragments. The digested products were then 
run on a 2.5% agarose gel (Cinnagen-Iran) and 
visualized on UV transilluminator after 
staining with ethidium bromide. 
Polymorphisms at position +874 of IFN-γ gene 
were identified using allele specific 
polymerase chain reaction (ARMS-PCR) as 
described by Pravica and colleagues (7). The 
262 bp amplified product was then visualized 
by electrophoresis on 2% agarose gel. 
 
Statistical analysis 
Allele and genotype frequencies were 
calculated in patients and healthy controls by 
direct gene counting. Statistical analysis of the 
differences between groups was determined by 
χ
2 test using EPI 2000 and SPSS software 
version 13. The P value less than 0.05 was 
considered significant. The study power was 
also calculated for each allele and genotype. 
 
Results 
In this study IFN-γ and IL-4 gene 
polymorphisms were analyzed in 160 type 2  
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diabetic patients and 160 healthy controls. The 
demographic information such as age, sex, 
race and socio-economic status of patients and 
healthy controls are shown in Table 1. As it is 
obvious from Table 1 the mean age of patients 
and healthy controls is between 38±9 and 
38±8, respectively. There is not a significant 
difference between the age of patients and 
healthy controls. 40% of patients were female 
and 60% were male while 41% of healthy 
controls were female and 59% male. As shown 
in Table 1, there was not a significant 
difference in socio-economic status of patients 
compared to healthy controls either. 
Polymorphisms  results  of  +874  region  of         
IFN-γ and -590 region of IL-4 are shown in 
Tables 2 and 3.  
 
Table1. Demographic data including age, sex and socio-economic status of diabetic patients and healthy controls. 
Number Variant Healthy  control  Patient 
1 SD  of  age  38±8  38±9 
  Female  64 (40%)  66 (41%) 
2 Male 
 
Sex  96 (60%)  94 (59%) 
  Weak    38 (24%)  34 (21%) 
3  Midway  Socio-economic status  70 (44%)  78 (49%) 
  High    52 (32%)  48 (30%) 
 
Table 2. Polymorphisms results of +874 region of IFN-γ. Chi-Square: 2.321, df: 2,  P: 0.313.  
Total  
n (%)   
AA  
n (%)   
AT  
n (%)   
TT  
n (%)  
Polymorphisms   
  
Condition        
160   
100%  
24  
15.1%  
51  
31.8%   
85   
53.1%  
Patient  
160  
100%   
26  
26.3%   
54   
33.7%   
80  
50%  
Healthy control  
   P>0.3    P>0.3    P>0.3    P value  
 
Table 3. Polymorphisms results of -590 region of IL-4. Chi-Square: 2.321, df: 2,  P: 0.16  
Total  
n (%)   
TT  
n (%)   
CT  
n (%)   
CC  
n (%)       
Polymorphisms 
 
Condition      
160   
100%  
13   
8.2%  
35  
21.8%   
112  
70%   
Patient   
160  
100%   
11   
6.9%   
33   
20.6%   
116   
72.5%   
Healthy control   
   P>0.1    P>0.1    P>0.1    Total   
 
 
Discussion 
Immune system plays key roles in 
pathogenesis of type 2 diabetes (2). Cytokines 
are key mediators which regulate immune 
response and it is well established that 
expression of cytokines by immune cells 
depends on several factors such as infection, 
inflammation, hormonal condition and also 
cytokines gene polymorphisms (1, 8). In this 
study, we analyzed gene polymorphisms of 
IFN-γ as Th1 and IL-4 as Th2 cytokines in 
type 2 diabetic patients. We selected the gene 
regions which influence expression of these 
genes for comparison in type 2 diabetic 
patients and healthy controls. As it is obvious 
in Table 1 the two groups had same age, sex, 
ethnic group and socio-economical condition. 
We could not find a significant difference 
between patients and control group regarding  
-590 region of IL-4 gene (Table 2). Our study 
showed that in +874 of IFN-γ gene, TT alleles 
is more expressed in diabetic patients than 
healthy controls but the difference was not 
significant but it seems that it would be 
significant if more samples had been analyzed. 
Tsiavou and colleagues showed that in +874 
region of IFN-γ gene, polymorphism is 
associated with type 2 diabetes and AA allele 
is significantly higher in diabetic patients in 
Greece (9). Their results are interesting  
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because they showed that the presence of this 
allele is associated with down-regulation of 
IFN-γ. Several research teams showed 
increased expression of IFN-γ in type 2 
diabetic patients (9, 10); thus, complementary 
studies are needed in type 2 diabetes to cover 
the gap of knowledge in this field. Although, 
our results did not show any significant 
difference in TT allele in IFN-γ, it was 
increased in diabetic patients. Therefore, it is 
probable that with a larger sample an 
association of this polymorphism with type 2 
diabetes can be found. To the extent of our 
knowledge, there is not much information 
related to these polymorphisms and diabetes, 
however association between these 
polymorphisms and brocella (11), lishmaniosis 
(12), tuberculosis (13) and malaria (14) was 
reported.  Hanck  et al, analyzed IFN-γ 
polymorphisms in patients with alcoholic 
chronic pancreatitis but  did not find any 
association between the different genotypes 
and the clinical course of the disease. 
Therefore, they assumed that these genetic 
variants did not play an important role in 
alcoholic chronic pancreatitis (15). 
In another report Rafinejad et al, examined 
the relation between IFN-γ gene 
polymorphisms and type 1 diabetes and found 
 a significant difference between patient and 
control groups in TT genotype (16). Overall 
these results and other research teams’ 
investigations give perspectives to the etiology 
of diabetes. 
For future studies, analysis of other cytokine 
gene polymorphisms such as IFN-γ, TNF-α 
and IL-12 as the main cellular immunity 
cytokines is suggested, since it seems that Th2 
cytokines (like IL-4) suppress the cellular 
immunity and may not play a clinical role in 
etiology and genetic of diabetes. 
 
Conclusion 
The results of this study demonstrated that 
there is not any relation between IFN-γ and   
IL-4 polymorphisms and type 2 diabetes. 
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